CEO Spotlight: Pat LePore, Par Pharmaceutical Companies

NYFP 2012-04-25

Views 65

04/24/2012 Pat LePore, Chairman and CEO of Par Pharmaceutical Companies discusses the latest developments for the company in the generic drug market. Par Pharmaceutical Companies celebrated the 25th anniversary of its listing on the NYSE.

Share This Video


Download

  
Report form
RELATED VIDEOS